Left Atrial Diameter and Atrial Ectopic Burden in Patients with Embolic Stroke of Undetermined Source: Risk Stratification of Atrial Fibrillation with Insertable Cardiac Monitor Analysis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose An insertable cardiac monitor (ICM) has been demonstrated to be a useful tool for detecting subclinical atrial fibrillation (AF) in patients with embolic stroke of undetermined source (ESUS). This study aimed to identify the clinical predictors of AF in ESUS patients with ICMs. Methods We retrospectively selected consecutive patients with an ICM implanted for AF detection following ESUS. The primary endpoint was defined as any AF episode lasting for longer than 5 min. The atrial ectopic burden (AEB) was calculated as the percentage of the number of conducted QRS from atrial ectopy on Holter monitoring. Results This study included 136 patients. AF lasting ≥5 min was detected in 20 patients (14.7%) during a median follow-up period of 6.6 months (interquartile range, 3.3–10.8 months). AF patients had a higher AEB (0.20% vs. 0.02%, p<0.001) and a larger left atrial diameter (LAD, 41.0 mm vs. 35.3 mm, p<0.001) than those without AF. The areas under the receiver operating characteristic curves were 0.795 and 0.816 for the LAD and log-transformed AEB, respectively, for the best cutoff values of 38.5 mm for LAD and 0.050% for AEB. AF lasting ≥5 min was detected in 34.6% (9/26) of patients with LAD ≥38.5 mm and AEB ≥0.050%, and in 0% (0/65) of those with LAD <38.5 mm and AEB <0.050%. Conclusions AF was detected in a significant proportion of ESUS patients during a 6.6-month follow-up. The LAD and AEB are good predictors of AF and might be useful for AF risk stratification in ESUS patients.
Abstract
Background and Purpose An insertable cardiac monitor (ICM) has been demonstrated to be a useful tool for detecting subclinical atrial fibrillation (AF) in patients with embolic stroke of undetermined source (ESUS). This study aimed to identify the clinical predictors of AF in ESUS patients with ICMs. Methods We retrospectively selected consecutive patients with an ICM implanted for AF detection following ESUS. The primary endpoint was defined as any AF episode lasting for longer than 5 min. The atrial ectopic burden (AEB) was calculated as the percentage of the number of conducted QRS from atrial ectopy on Holter monitoring. Results This study included 136 patients. AF lasting ≥5 min was detected in 20 patients (14.7%) during a median follow-up period of 6.6 months (interquartile range, 3.3–10.8 months). AF patients had a higher AEB (0.20% vs. 0.02%, p<0.001) and a larger left atrial diameter (LAD, 41.0 mm vs. 35.3 mm, p<0.001) than those without AF. The areas under the receiver operating characteristic curves were 0.795 and 0.816 for the LAD and log-transformed AEB, respectively, for the best cutoff values of 38.5 mm for LAD and 0.050% for AEB. AF lasting ≥5 min was detected in 34.6% (9/26) of patients with LAD ≥38.5 mm and AEB ≥0.050%, and in 0% (0/65) of those with LAD <38.5 mm and AEB <0.050%. Conclusions AF was detected in a significant proportion of ESUS patients during a 6.6-month follow-up. The LAD and AEB are good predictors of AF and might be useful for AF risk stratification in ESUS patients.
참고문헌 (24)
- Finsterer J, "Management of cryptogenic stroke", Acta Neurol Belg, 110, pp.135~147 (2010)
- Hart RG, "Embolic strokes of undetermined source : the case for a new clinical construct", Lancet Neurol, 13, pp.429~438 (2014)
- De Angelis MV, "Cryptogenic stroke and atrial fibrillation in a realworld population : the role of insertable cardiac monitors", Sci Rep, 10, pp.3230~ (2020)
- Kirchhof P, "2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS", Europace, 18, pp.1609~1678 (2016)
- Giancaterino S, "Current and future use of insertable cardiac monitors", JACC Clin Electrophysiol, 4, pp.1383~1396 (2018)
- Ziegler PD, "Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population", Int J Cardiol, 244, pp.175~179 (2017)
- Maervoet J, "Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is costeffective", J Med Econ, 22, pp.1221~1234 (2019)
- Kim BJ, "Current status of acute stroke management in Korea : a report on a multicenter, comprehensive acute stroke registry", Int J Stroke, 9, pp.514~518 (2014)
- Glotzer TV, "Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke : report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial(MOST)", Circulation, 107, pp.1614~1619 (2003)
- Jiamsripong P, "Three methods for evaluation of left atrial volume", Eur J Echocardiogr, 9, pp.351~355 (2008)
- Brachmann J, "Uncovering atrial fibrillation beyond short-term monitoring in cryptogenic stroke patients : three-year results from the cryptogenic stroke and underlying atrial fibrillation trial", Circ Arrhythm Electrophysiol, 9, pp.e003333~ (2016)
- Soliman EZ, "Factors modifying the risk of atrial fibrillation associated with atrial premature complexes in patients with hypertension", Am J Cardiol, 125, pp.1324~1331 (2020)
- Gladstone DJ, "Atrial premature beats predict atrial fibrillation in cryptogenic stroke : results from the EMBRACE trial", Stroke, 46, pp.936~941 (2015)
- Thomas L, "Left atrial reverse remodeling : mechanisms, evaluation, and clinical significance", JACC Cardiovasc Imaging, 10, pp.65~77 (2017)
- Vollmuth C, "MR-imaging pattern is not a predictor of occult atrial fibrillation in patients with cryptogenic stroke", J Neurol, 266, pp.3058~3064 (2019)
- Diamantopoulos A, "Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke", Int J Stroke, 11, pp.302~312 (2016)
- Benjamin EJ, "Heart disease and stroke statistics-2019 update : a report from the American Heart Association", Circulation, 139, pp.e56~ (2019)
- Yaghi S, "Cryptogenic stroke : research and practice", Circ Res, 120, pp.527~540 (2017)
- Lovett JK, "Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies", Neurology, 62, pp.569~573 (2004)
- Kolominsky-Rabas PL, "Epidemiology of ischemic stroke subtypes according to TOAST criteria : incidence, recurrence, and long-term survival in ischemic stroke subtypes : a population-based study", Stroke, 32, pp.2735~2740 (2001)
- Sanna T, "Cryptogenic stroke and underlying atrial fibrillation", N Engl J Med, 370, pp.2478~2486 (2014)
- Francesca Bridge, "How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices", 대한뇌졸중영문학회지, 18(2), pp.121~128 (2016), 대한뇌졸중학회
- Van Gelder IC, "Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT", Eur Heart J, 38, pp.1339~1344 (2017)
- Glotzer TV, "The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk : the TRENDS study", Circ Arrhythm Electrophysiol, 2, pp.474~480 (2009)